On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - $216.03 /
+19.81 (+10.10%) - 05/25/23
- Workday jumps 8% to $213.00 after Q1 results beat estimates
- 05/25/23
- Workday reports Q1 subscription revenue $1.53B, up 20.1% y/y
- 05/25/23
- Workday raises FY24 subscription revenue view to $6.55B-$6.575B
- 05/25/23
- Workday names Zane Rowe as CFO succeeding Barbara Larson
WBA Walgreens Boots Alliance - 05/17/23
- San Francisco City announces $230M opioid settlement with Walgreens
- 05/12/23
- AmerisourceBergen announces common share repurchase from Walgreens Boots Alliance
- 05/12/23
- Walgreens Boots Alliance sells shares of AmerisourceBergen for $694M
- 05/02/23
- Writers Guild of America goes on strike after studio talks fail
- $420.13 /
-65.52 (-13.49%) - 05/25/23
- Ulta Beauty lowers FY23 operating margin view to 14.5%-14.8% from 14.7%-15.0%
- 05/25/23
- Ulta Beauty falls 8% to $446.50 after Q1 results and guidance
- 03/09/23
- Ulta Beauty sees operating margin at 14%-15% over next few years
- 02/05/23
- Fly Intel: Top five weekend stock stories
- $193.14 /
+8.715 (+4.73%) - 05/16/23
- Tesla CEO says we adjust pricing to match demand based on incoming daily data
- 05/16/23
- Tesla CEO says there's some 'good logic' to starting advertising to reach people
- 05/26/23
- Hexo announces ISS recommendation for arrangement with Tilray
- 05/25/23
- Tilray's SweetWater Brewing announces summer release of American Lager
- 05/25/23
- Tilray announces European market expansion in Italy
- 05/18/23
- SweetWater Brewing introduces Colorado Orange Citrus Ale
- 05/24/23
- Teva gets tentative approval of ANDA for tofacitnib
- 05/10/23
- Teva sees gradual pick up in margins in Q2, further progress in 2H
- 05/10/23
- Teva reaffirms FY23 free cash flow view $1.7B-$2.1B
- 05/10/23
- Teva sees first payment for U.S. opioid settlement in 2H23
- $71.43 /
+11.44 (+19.07%) - 05/15/23
- Tiger Global buys TSMC, exits AppLovin in Q1
- 03/20/23
- Pinduoduo falls 16% to $76.85 after reporting Q4 results
- 12/27/22
- China stocks rising with borders set to reopen on January 8
- 12/23/22
- PCAOB chair 'applauds' Congressional action to shorten HFCAA timeline
- 05/17/23
- Paramount director buys $2.5M in common stock
- 04/21/23
- Paramount directors agree to $167.5M settlement over merger litigation
- 03/01/23
- User reports indicate problems at Paramount+, Downdetector says
- 05/15/23
- Berkshire Hathaway takes stake in Capital One, exits RH
- 05/04/23
- Paramount to reduce quarterly dividend to 5c per share
- 05/04/23
- Paramount says aiming for positive free cash flow in 2024
- 05/26/23
- New Relic falls 3% after Reuters says private equity buyout talks ended
- 05/17/23
- New Relic rises after WSJ says PE firms in takeover talks
- 05/17/23
- New Relic jumps 11% to $83.97 on acquisition speculation by WSJ
- 05/15/23
- Jana exited Encompass Health during Q1, bought more FIS
- $65.51 /
+16.055 (+32.47%) - 05/25/23
- Marvell jumps 18% to $58.37 after Q1 results, Q2 guidance beat estimates
- 05/25/23
- Marvell reports Q1 adjusted gross margin 60%
- 04/18/23
- EU takes on US and Asia with EUR 43B chip subsidy plan
- 02/23/23
- Marvell unveils OCTEON 10 fusion processor family for 5G networks
- $283.32 /
-1.915 (-0.67%) - 05/25/23
- MongoDB and Alibaba announce four-year partnership extension
- 03/08/23
- MongoDB sees Q1 Atlas revenue flat to down sequentially
- 03/08/23
- MongoDB falls 10% to $206.50 after Q1, FY24 revenue views miss estimates
- 01/19/23
- Satori adds support for MongoDB NoSQL database
- 04/27/23
- Terran Orbital receives milestone payment for 300 spacecraft
- 02/22/23
- Terran Orbital rises 94.2%
- 02/22/23
- Terran Orbital awarded $2.4B contract to build 300 satellites for Rivada Space
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 05/23/23
- Climb Global signs $50M credit facility with JPMorgan Chase
- 05/22/23
- Tegna announces $300M ASR agreement with JPMorgan Chase Bank
- 05/22/23
- Dimon says 'everybody should be prepared for higher rates from here'
- 05/22/23
- JPMorgan's Dimon says board will decide post-CCAR on dividend
- 05/26/23
- Hibbett CEO says 'our consumers are facing a number of headwinds'
- 03/03/23
- Hibbett sees FY24 CapEx $60M-$70M
- 03/03/23
- Hibbett sees FY24 gross margin down 20-30 bps vs. FY23
- 03/03/23
- Hibbett CEO sees 'several headwinds' in FY24
- 05/26/23
- Gap rises 14.6%
- 05/26/23
- Gap rises 11.2%
- 05/25/23
- Gap jumps 14% to $8.50 after Q1 results, FY23 guidance
- 05/25/23
- Gap reports Q1 online sales decreased 9% compared to last year
- 05/09/23
- Guardant Health presents additional data from ECLIPSE study
- 05/08/23
- Guardant Health names Ines Dahne-Steuber as chief operating officer
- 04/18/23
- Guardant Health gets Medicare coverage for Guardant360 Response test
- 03/21/23
- Guardant Health teams with Ohio State to study CRC screening adherence
- 05/25/23
- Geron: Data support NDA submission for imetelstat on track for June 2023
- 05/11/23
- Geron to report updated durability, favorable PRO at EHA annual meeting
- 05/11/23
- Geron sees FY23 expenses $200M-$210M
- 05/08/23
- Marker Therapeutics appoints Monic Stuart as Chief Medical Officer
- 05/25/23
- CRE exposure may pressure ratings of regional banks, Fitch Ratings says
- 05/25/23
- Ford EV customers to gain access to 12,000 Tesla superchargers
- 05/25/23
- Ford, Tesla CEOs to host Twitter Spaces chat on accelerating EV adoption
- 05/22/23
- SQM announces long-term lithium supply agreement with Ford
- 05/22/23
- Ford sees Ford Blue EBIT margin in low double digits by 2026
EFTR eFfector Therapeutics - 05/25/23
- eFfector Therapeutics' zotatifin shows positive Phase 2 breast cancer results
- 04/11/23
- eFfector Therapeutics to collaborate with Standford Medicine
- 02/21/23
- eFfector announces top-line results from Phase 1b trial of zotatifin
- 01/05/23
- eFfector Therapeutics provides clinical data update for Zotatifin
- $11.41 /
-2.415 (-17.47%) - 05/26/23
- DLocal says not notified by any Argentinian authority of foreign exchange probe
- 05/26/23
- DLocal says article published by Infobae includes 'misleading allegations'
- 05/17/23
- DLocal boosts headcount by 36% year-over-year to 763 employees in Q1
- 04/05/23
- DLocal down 11% in pre-market after Q4 earnings miss reported last night
- 05/24/23
- CMA provisionally finds five banks broke competition law on U.K. bonds
- 05/03/23
- Deutsche Bank raises prime lending rate to 8.25% from 8.00%, effective May 4
- 04/28/23
- Deutsche Bank to combine U.K., Ireland corporate finance unit with Numis
- 04/27/23
- Deutsche Bank 'fully committed' to further capital distributions in 2023
- $507.32 /
+20.265 (+4.16%) - 05/17/23
- Grove announces new retail partnerships with Kroger, Costco and Hannaford
- 05/03/23
- Costco reports April sales of $17.85B
- 04/19/23
- Costco increases quarterly cash dividend to $1.02 per share
- 04/05/23
- Costco down 3% afterhours following March sales data
- 05/26/23
- ConocoPhillips to also pay contigent payments of up to $325M
- 05/26/23
- ConocoPhillips buying remaining 50% interest in Surmont from TotalEnergies EP
- 05/26/23
- ConocoPhillips to buy remaining 50% interest in Surmont for $3B
- 05/26/23
- ConocoPhillips exercising preemption right to buy 50% interest in Surmont
- 05/26/23
- Coherent, Mitsubishi Electric enter collaboration
- 05/10/23
- Coherent falls 12% to $28.00 after Q3 results, guidance miss estimates
- 05/10/23
- Coherent commences certain restructuring actions
- 04/06/23
- Coherent falls -9.9%
- 05/26/23
- Big Lots falls -15.1%
- 05/26/23
- Big Lots falls -18.7%
- 05/26/23
- Big Lots falls -12.8%
- 05/26/23
- Big Lots announces suspension of dividend
- 05/15/23
- Canadian Solar subsidiary signs aggregation deal for 100MW in Texas
- 03/27/23
- Autodesk names Sebastian Goodwin chief trust officer
- 02/21/23
- Procore announces Sarah Hodges as CMO, effective immediately
- 02/14/23
- Lone Pine exited PayPal, initiated AMD position during Q4
WBA Walgreens Boots Alliance - 03/30/23 Deutsche Bank
- Walgreens Boots Alliance price target lowered to $46 from $47 at Deutsche Bank
- 03/29/23 UBS
- Walgreens Boots Alliance price target lowered to $37 from $39 at UBS
- 03/29/23 Truist
- Walgreens Boots Alliance price target lowered to $40 from $42 at Truist
- 03/26/23 Barclays
- Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays
- 05/23/23 Morgan Stanley
- JPMorgan price target raised to $160 from $157 at Morgan Stanley
- 05/15/23 Jefferies
- JPMorgan price target lowered to $149 from $152 at Jefferies
- 05/12/23 Citi
- State Street, BNY Mellon hurt most from FDIC proposal, says Citi
- 05/12/23 Evercore ISI
- JPMorgan price target lowered to $151 from $155 at Evercore ISI
- 05/25/23 Morgan Stanley
- Teva initiated with an Equal Weight at Morgan Stanley
- 05/18/23 Evercore ISI
- Teva upgraded to Outperform at Evercore ISI on TL1A and olanzapine potential
- 05/18/23 Evercore ISI
- Teva upgraded to Outperform from In Line at Evercore ISI
- 05/11/23 BofA
- Teva pullback a 'particularly attractive opportunity,' says BofA
- 05/26/23 DA Davidson
- DA Davidson positive on New Relic ability to accelerate growth
- 05/26/23 RBC Capital
- RBC upgrades New Relic on accelerating growth visibility
- 05/26/23 RBC Capital
- New Relic upgraded to Outperform from Sector Perform at RBC Capital
- 05/24/23 Truist
- New Relic price target raised to $77 from $65 at Truist
- 05/04/23 Citi
- Deutsche Bank upgraded to Buy from Neutral at Citi
- 04/24/23 Barclays
- Deutsche Bank price target lowered to EUR 12 from EUR 12.50 at Barclays
- 02/10/23 BofA
- Deutsche Bank downgraded to Underperform from Neutral at BofA
- 02/08/23 UBS
- Deutsche Bank price target raised to EUR 18.80 from EUR 16.30 at UBS
- 05/25/23 Daiwa
- Ford upgraded to Neutral from Underperform at Daiwa
- 05/17/23 Deutsche Bank
- Deutsche says Ford event may clear way for investor caution
- 05/15/23 Citi
- Ford price target raised to $12.80 from $12.50 at Citi
- 05/03/23 Benchmark
- Ford price target raised to $20 from $19 at Benchmark
- $507.32 /
+20.265 (+4.16%) - 05/26/23 Loop Capital
- Costco price target lowered to $545 from $550 at Loop Capital
- 05/26/23 Roth MKM
- Costco price target lowered to $482 from $492 at Roth MKM
- 05/26/23 UBS
- Costco price target lowered to $560 from $575 at UBS
- 05/04/23 Truist
- Costco price target lowered to $568 from $571 at Truist
- $193.14 /
+8.715 (+4.73%) - 05/23/23 Oppenheimer
- Shares may move higher near-term as Tesla outperforms peers, says Oppenheimer
- 05/18/23 Wedbush
- Wedbush says Tesla/Musk strategy feels solid as investors focus on price wars
- 05/17/23 Wedbush
- Potential advertising campaign 'a major positive' for Tesla, says Wedbush
- 05/17/23 Bernstein
- 2024 could be even more challenging for Tesla, says Bernstein
- $216.03 /
+19.81 (+10.10%) - 05/26/23 Loop Capital
- Workday price target raised to $210 from $180 at Loop Capital
- 05/26/23 BMO Capital
- Workday price target raised to $240 from $205 at BMO Capital
- 05/26/23 Evercore ISI
- Workday price target raised to $240 from $225 at Evercore ISI
- 05/26/23 Canaccord
- Workday price target raised to $240 from $210 at Canaccord
- 05/26/23 BofA
- Gap price target lowered to $8.50 from $9.50 at BofA
- 05/26/23 Baird
- Gap price target lowered to $10 from $12 at Baird
- 05/19/23 Citi
- Gap upgraded to Neutral from Sell at Citi
- 05/09/23 Jefferies
- Gap price target lowered to $9 from $11 at Jefferies
- 05/19/23 Mizuho
- ConocoPhillips price target lowered to $126 from $128 at Mizuho
- 05/18/23 Piper Sandler
- ConocoPhillips price target raised to $149 from $140 at Piper Sandler
- 05/15/23 Morgan Stanley
- ConocoPhillips price target raised to $124 from $122 at Morgan Stanley
- 05/01/23 Goldman Sachs
- Exxon Mobil downgraded to Neutral from Buy at Goldman Sachs
- 05/19/23 Deutsche Bank
- TotalEnergies price target raised to EUR 59.80 from EUR 56.20 at Deutsche Bank
- 05/18/23 Piper Sandler
- TotalEnergies price target lowered to $68 from $69 at Piper Sandler
- 04/19/23 JPMorgan
- TotalEnergies price target lowered to EUR 69 from EUR 73 at JPMorgan
- 04/11/23 Redburn
- TotalEnergies upgraded to Neutral from Sell at Redburn
- 05/26/23 Citi
- Citi upgrades Guardant Health to Buy with key overhangs removed
- 05/26/23 Citi
- Guardant Health upgraded to Buy from Neutral at Citi
- 05/15/23 Piper Sandler
- Guardant Health price target lowered to $30 from $35 at Piper Sandler
- 05/10/23 Craig-Hallum
- Craig-Hallum upgrades Exact Sciences to Buy, raises price target to $85
- $283.32 /
-1.915 (-0.67%) - 05/26/23 Guggenheim
- MongoDB downgraded to Sell at Guggenheim on growth and valuation concerns
- 05/25/23 Guggenheim
- MongoDB downgraded to Sell from Neutral at Guggenheim
- 05/15/23 Barclays
- MongoDB price target raised to $280 from $257 at Barclays
- 05/26/23 Loop Capital
- Loop Capital upgrades Paramount to Hold as controlling shareholder raises funds
- 05/26/23 Loop Capital
- Paramount upgraded to Hold from Sell at Loop Capital
- 05/24/23 Deutsche Bank
- Paramount price target lowered to $25 from $28 at Deutsche Bank
EFTR eFfector Therapeutics - 05/26/23 Mizuho
- eFfector Therapeutics posted positive breast cancer data, says Mizuho
- 05/26/23 Stifel
- eFfector Therapeutics upgraded to Buy from Hold at Stifel
- 05/26/23 BofA
- Terran Orbital double downgraded to Underperform at BofA
- 05/26/23 BofA
- Terran Orbital downgraded to Underperform from Buy at BofA
- 05/16/23 B. Riley
- Terran Orbital price target lowered to $7.50 from $10 at B. Riley
- 05/16/23 Stifel
- Terran Orbital price target lowered to $7 from $8 at Stifel
- 05/12/23 Northland
- Coherent price target lowered to $38 from $52.50 at Northland
- 05/11/23 Deutsche Bank
- Coherent price target lowered to $40 from $45 at Deutsche Bank
- 05/11/23 B. Riley
- Coherent price target lowered to $47 from $67 at B. Riley
- 05/11/23 Craig-Hallum
- Coherent price target lowered to $38 from $57 at Craig-Hallum
- $71.43 /
+11.44 (+19.07%) - 05/02/23 Citi
- PDD Holdings price target lowered to $100 from $115 at Citi
- 04/24/23 Goldman Sachs
- PDD Holdings cut to Neutral at Goldman Sachs amid ad growth moderation
- 04/24/23 Goldman Sachs
- PDD Holdings downgraded to Neutral from Buy at Goldman Sachs
- 04/13/23 UBS
- JD.com downgraded to Neutral at UBS on competitive headwinds
- 03/27/23 Goldman Sachs
- Geron initiated with a Neutral at Goldman Sachs
- 01/09/23 B. Riley
- Geron price target raised to $5 from $4 at B. Riley
- 01/04/23 Wedbush
- Wedbush raises Geron price target to $6 following Phase 3 IMerge study data
- 10/28/22 Wedbush
- Wedbush starts Geron with Outperform, $5 price target
- 04/12/23 Roth MKM
- Tilray price target lowered to $2.50 from $3.00 at Roth MKM
- 04/11/23 TD Cowen
- Tilray price target lowered to $5 from $9 at TD Cowen
- 01/10/23 MKM Partners
- Tilray price target lowered to $3 from $4 at MKM Partners
- 01/10/23 Canaccord
- Tilray price target lowered to $5 from $7 at Canaccord
- $11.41 /
-2.415 (-17.47%) - 05/19/23 BofA
- DLocal price target raised to $16 from $15 at BofA
- 05/11/23 Barclays
- DLocal initiated with an Underweight at Barclays
- 04/13/23 HSBC
- DLocal downgraded to Hold at HSBC on near-term margin pressure
- 04/13/23 HSBC
- DLocal downgraded to Hold from Buy at HSBC
- $65.51 /
+16.055 (+32.47%) - 05/26/23 Needham
- Marvell price target raised to $65 from $50 at Needham
- 05/26/23 Evercore ISI
- Marvell price target raised to $70 from $60 at Evercore ISI
- 05/26/23 Raymond James
- Marvell price target raised to $64 from $50 at Raymond James
- 05/26/23 Craig-Hallum
- Marvell price target raised to $67 from $56 at Craig-Hallum
- $420.13 /
-65.52 (-13.49%) - 05/26/23 Loop Capital
- Ulta Beauty price target lowered to $490 from $535 at Loop Capital
- 05/26/23 Raymond James
- Ulta Beauty price target lowered to $600 from $615 at Raymond James
- 05/26/23 DA Davidson
- Ulta Beauty price target lowered to $540 from $620 at DA Davidson
- 05/26/23 Oppenheimer
- Ulta Beauty price target lowered to $540 from $575 at Oppenheimer
- 05/24/23 BMO Capital
- Autodesk initiated with a Market Perform at BMO Capital
- 05/23/23 Citi
- Autodesk price target lowered to $241 from $265 at Citi
- 05/19/23 Baird
- Autodesk price target lowered to $230 from $247 at Baird
- 05/19/23 Stifel
- Autodesk price target lowered to $240 from $245 at Stifel
- 05/26/23 Baird
- Hibbett price target lowered to $50 from $80 at Baird
- 05/26/23 BofA
- Hibbett downgraded to Underperform from Buy at BofA
- 05/26/23 Williams Trading
- Hibbett cut to Sell at Williams Trading after 'far worse' than expected outlook
- 05/26/23 Williams Trading
- Hibbett downgraded to Sell from Hold at Williams Trading
- 04/21/23 Piper Sandler
- Big Lots downgraded to Underweight from Neutral at Piper Sandler
- 01/05/23 Deutsche Bank
- Big Lots price target lowered to $9 from $10 at Deutsche Bank
- 12/19/22 Credit Suisse
- Big Lots initiated with an Underperform at Credit Suisse
- 12/06/22 Deutsche Bank
- Big Lots price target lowered to $10 from $13 at Deutsche Bank
- $216.03 /
+19.81 (+10.10%) - 05/25/23
- Workday reports Q1 adjusted EPS $1.32, consensus $1.12
- 02/27/23
- Workday reports Q4 EPS $1.00, consensus 91c
- 02/27/23
- Notable companies reporting after market close
WBA Walgreens Boots Alliance - 03/28/23
- Walgreens Boots reaffirms FY23 adjusted EPS view $4.45-$4.65, consensus $4.51
- 03/28/23
- Walgreens Boots Alliance reports Q2 adjusted EPS $1.16, consensus $1.10
- 03/27/23
- Notable companies reporting before tomorrow's open
- $420.13 /
-65.52 (-13.49%) - 05/25/23
- Ulta Beauty backs FY23 EPS view at $24.70-$25.40
- 05/25/23
- Ulta Beauty reports Q1 EPS $6.88, consensus $6.87
- 03/09/23
- Ulta Beauty guides initial FY23 EPS $24.70-$25.40, consensus $24.25
- 02/08/23
- TotalEnergies reports Q4 EPS $2.97, consensus $3.03
- $193.14 /
+8.715 (+4.73%) - 04/19/23
- Tesla reports Q1 EPS 85c, consensus 85c
- 04/19/23
- Notable companies reporting after market close
- 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 04/10/23
- Tilray reports Q3 EPS ($1.90) vs. 9c last year
- 01/09/23
- Tilray reports Q2 adjusted EPS (6c) vs. (8c) last year
- 05/10/23
- Teva backs FY23 EPS $2.25 - $2.55, consensus $2.40
- 05/10/23
- Teva reports Q1 EPS 40c, consensus 56c
- 02/08/23
- Teva sees FY23 EPS $2.25-$2.55, consensus $2.52
- 02/08/23
- Teva reports Q4 EPS 71c, consensus 71c
- $71.43 /
+11.44 (+19.07%) - 05/26/23
- PDD Holdings reports Q1 adjusted EPS $1.01, consensus 54c
- 03/20/23
- Pinduoduo reports Q4 adjusted EPS $1.21, consensus $1.21
- 11/28/22
- Pinduoduo reports Q3 adjusted EPS $1.21, consensus 65c
- 05/04/23
- Paramount reports Q1 EPS 9c, consensus 17c
- 02/16/23
- Paramount sees Q1 OIBDA similar to Q4; expects a Q1 EPS loss
- 05/25/23
- New Relic sees long-range top line growth of 20%-25%
- 05/23/23
- New Relic sees FY24 revenue $1.02B-$1.03B, consensus $1.07B
- 05/23/23
- New Relic sees Q1 revenue $238M-$240M, consensus $251.15M
- 05/23/23
- New Relic reports Q4 adjusted EPS 42c, consensus 22c
- $65.51 /
+16.055 (+32.47%) - 05/25/23
- Marvell sees Q2 adjusted EPS 32c, +/- 5c per share, consensus 31c
- 05/25/23
- Marvell reports Q1 adjusted EPS 31c, consensus 29c
- 03/02/23
- Marvell sees Q1 non-GAAP EPS 24c-34c, consensus 41c
- $283.32 /
-1.915 (-0.67%) - 03/08/23
- MongoDB sees FY24 adjusted EPS 96c-$1.10, consensus 61c
- 03/08/23
- MongoDB sees Q1 adjusted EPS 17c-20c, consensus 14c
- 03/08/23
- MongoDB reports Q4 adjusted EPS 57c, consensus 7c
- 03/08/23
- Notable companies reporting after market close
- 05/15/23
- Terran Orbital sees 2023 revenue above $250M, consensus $199.24M
- 05/15/23
- Terran Orbital reports Q1 EPS (38c), consensus (19c)
- 03/21/23
- Terran Orbital reports Q4 EPS (23c) vs. (51c) last year
- 05/22/23
- JPMorgan now sees FY NII ex-Markets $84B due to First Republic
- 04/14/23
- JPMorgan reports Q1 EPS $4.10, consensus $3.41
- 04/13/23
- Notable companies reporting before tomorrow's open
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 05/26/23
- Hibbett cuts FY24 EPS view to $7.00-$7.75 from $9.50-$10.0, consensus $9.14
- 05/26/23
- Hibbett reports Q1 EPS $2.74, consensus $3.04
- 03/03/23
- Hibbett sees FY24 EPS $9.50-$10.0, consensus $10.40
- 03/03/23
- Hibbett reports Q4 EPS $2.91, consensus $2.94
- 05/25/23
- Gap sees FY23 revenue down low to mid-single digit range, consensus $15.07B
- 05/25/23
- Gap sees Q2 revenue down mid to high-single digit range, consensus $3.67B
- 05/25/23
- Gap reports Q1 adjusted EPS 1c, consensus (16c)
- 05/09/23
- Guardant Health raises FY23 revenue view to $535M-$545M, consensus $533.48M
- 05/09/23
- Guardant Health reports Q1 adjusted EPS ($1.06), consensus ($1.31)
- 02/23/23
- Guardant Health sees FY23 revenue $525M-$540M, consensus $554M
- 02/23/23
- Guardant Health reports Q4 EPS ($1.17), consensus ($1.37)
- 05/11/23
- Geron reports Q1 EPS (7c), consensus (10c)
- 03/16/23
- Geron reports Q4 EPS (10c), consensus (12c)
- 05/22/23
- Ford backs FY23 adjusted EBIT view of $9B-$11B
- 05/02/23
- Ford reports Q1 adjusted EPS 63c, consensus 41c
- 05/02/23
- Notable companies reporting after market close
- 05/01/23
- Notable companies reporting before tomorrow's open
EFTR eFfector Therapeutics - 05/09/23
- eFfector Therapeutics reports Q1 EPS (24c), consensus (14c)
- 03/08/23
- eFfector Therapeutics reports Q4 EPS (22c), consensus (24c)
- $11.41 /
-2.415 (-17.47%) - 05/17/23
- DLocal reports Q1 EPS 11c, consensus 11c
- 04/05/23
- DLocal sees FY23 revenue $620M-$640M, consensus $613.7M
- 04/05/23
- DLocal reports Q4 EPS 6c, consensus 11c
- 04/27/23
- Deutsche Bank reports Q1 profit before tax up 12% y/y to EUR 1.9B
- 02/02/23
- Deutsche Bank reports Q4 profit before tax EUR 775M vs. EUR 82M last year
- $507.32 /
+20.265 (+4.16%) - 05/25/23
- Costco reports Q3 EPS $2.93, consensus $3.29
- 05/25/23
- Notable companies reporting after market close
- 03/02/23
- Costco reports Q2 EPS $3.30, consensus $3.21
- 03/02/23
- Notable companies reporting after market close
- 05/04/23
- ConocoPhillips reports Q1 EPS $2.38, consensus $2.10
- 05/03/23
- Notable companies reporting before tomorrow's open
- 02/02/23
- ConocoPhillips reports Q4 EPS $2.71, consensus $2.81
- 05/10/23
- Coherent sees FY23 revenue $5.08B-$5.15B, consensus $5.4B
- 05/10/23
- Coherent sees Q4 adjusted EPS 33c-43c, consensus 87c
- 05/10/23
- Coherent reports Q3 adjusted EPS 58c, consensus 82c
- 05/26/23
- Big Lots reports Q1 adjusted EPS ($3.40), consensus ($1.77)
- 03/02/23
- Big Lots reports Q4 adjusted EPS (28c), consensus (85c)
- 12/01/22
- Big Lots reports Q3 adjusted EPS ($2.99), consensus ($2.94)
- 05/25/23
- Autodesk sees FY24 non-GAAP EPS $7.07-$7.41, consensus $7.23
- 05/25/23
- Autodesk sees Q2 non-GAAP EPS $1.70-$1.74, consensus $1.77
- 05/25/23
- Autodesk reports Q1 non-GAAP EPS $1.55, consensus $1.55
|